Audit Trails for AI: Making Healthcare Automation Defensible at Scale

Healthcare AI has crossed a quiet but consequential threshold. These systems are no longer experimental aids operating at the margins of decision-making. They now sit directly inside claims adjudication, prior authorization, and payment workflows, committing organizations to outcomes that carry financial, regulatory, and legal consequences. As automation moves deeper into these workflows, accuracy alone is no longer the defining metric. What matters is whether an AI decision can be reconstructed, justified, and defended long after it is made.

This distinction is subtle but decisive. An automated decision that cannot explain itself under scrutiny is operationally fragile, regardless of how confident or statistically sound it appeared at the moment of execution. The real risk in healthcare AI today is not that systems make mistakes, but that they cannot account for themselves once challenged.

Few practitioners have worked as close to this fault line as Pradeesh Ashokan, a senior quality engineering leader and a 2025 TITAN Innovation Awards Silver winner, whose work spans AI-driven claims auditing, regulated healthcare platforms, and large-scale automation operating under payer scrutiny. Having led quality assurance for systems where automated decisions routinely surface in audits, appeals, and regulatory review cycles, Ashokan has seen firsthand why defensibility, not performance alone, has become the limiting factor for healthcare AI at scale.

AI systems are improving in accuracy, yet disputes and regulatory pressure continue to rise. What explains this disconnect?

The disconnect exists because healthcare is not a cooperative environment. It is adversarial by design. Claims decisions are routinely questioned by providers, patients, auditors, and regulators, often months after the original determination. AI models are optimized to produce outputs efficiently, but disputes demand something else entirely: a defensible narrative that connects inputs, rules, and reasoning into a coherent chain of evidence.

An accurate prediction without context becomes meaningless when an appeal arrives. At that point, confidence scores and aggregate performance metrics offer little protection. What matters is whether the system can show why a specific decision occurred, under which rules, using which data, and based on which version of logic. When that evidence is missing, trust erodes quickly, not because the system was wrong, but because it cannot prove that it was right.

When AI-driven decisions are challenged months later, what typically fails inside most systems?

What fails is not computation but memory. Many systems retain the final outcome while discarding the surrounding context that made the decision intelligible. When an appeal or audit surfaces, teams discover they cannot reliably reconstruct the exact data inputs, policy versions, or intermediate logic that produced the original result.

This failure mode is not limited to production systems. As an editorial board member and reviewer for ESP-IJACT, I routinely review AI research where models demonstrate strong benchmark performance, yet collapse under a simple question: could this decision be reproduced and defended once assumptions shift or inputs drift? In many cases, the answer is no—not because the model is weak, but because the system was never designed to preserve decision context beyond inference time.

Logs are rarely sufficient. Dashboards summarize behavior but do not preserve reasoning. Without a preserved lineage that ties clinical records, claim attributes, payer policies, and inference logic together, organizations are left with assertions instead of evidence. At that point, even correct decisions become indefensible, because there is no durable trail connecting cause to effect.

How does the risk profile change as AI begins to influence payments and denials rather than advisory or diagnostic decisions?

The difference is structural. Advisory systems support human judgment; financially binding systems replace it. Once AI influences payments and denials, every decision implicitly assumes it will be contested. These systems operate at payer scale, where throughput is high, stakes are financial, and scrutiny is routine.

This shift coincides with regulatory expectations becoming more explicit. The CMS Interoperability and Prior Authorization Final Rule, with implementation milestones reaching into early 2026, requires standardized decision workflows, tighter timelines, and transparent reporting around automated determinations. These requirements are not abstract. They directly expose how automated systems behave under load and how defensible their decisions are when viewed externally. In this environment, automation without accountability becomes a liability rather than an advantage.

From an engineering perspective, what makes an AI decision defensible rather than merely automated?

A defensible decision is one that can be replayed and explained without relying on institutional memory. That requires systems to preserve not just outcomes, but context. The exact data used at decision time must be immutable and retrievable. The policies and guidelines applied must be versioned and traceable. The model or rule logic involved must be identifiable, including the thresholds and conditions that shaped the final determination.

This is not documentation layered on after the fact. It is an architectural choice. Defensibility emerges when systems are designed to assume that every decision may one day need to justify itself to someone who was not present when it was made.

How does quality engineering change when the goal shifts from validating outcomes to validating reconstructability?

That shift became unavoidable for me while leading quality assurance for an AI-driven healthcare audit system operating inside payer claims workflows. In that environment, decisions trigger denials, payments, and audits, often resurfacing months later during appeals or regulatory review. Validating correctness at execution time was not enough. The real risk emerged when decisions could not be reconstructed under scrutiny.

At the time, QA focused on whether claims were flagged correctly, not whether the full decision context was preserved. As policies and logic evolved, historical decisions became harder to explain. Quality engineering had to expand from outcome validation to evidence preservation. We increased automated coverage to roughly 80% across core workflows and built more than 300 regression tests designed specifically to validate decision lineage. These tests ensured that each determination could be replayed with the same inputs, policy context, and versioned logic that existed at the time the decision was made, even as guidelines changed.

The impact was clear. Production incidents tied to unexplained or disputed decisions dropped by about 70%. Manual investigation time during audits and escalations was cut in half, and release validation cycles shortened by nearly 50% as traceability checks replaced ad-hoc review.

I explore this shift more deeply in my article published in the AI Journal titled From Model-Centric to System-Centric: Engineering AI That Actually Works, where I argue that the real unit of quality in AI systems is not the model’s output in isolation but the system’s ability to explain and reproduce that output over time.

That experience reshaped how I think about QA in healthcare AI. The goal is no longer to prove that a system works today but that its decisions remain defensible long after they are made.

Regulatory timelines and public reporting requirements are accelerating. Why is treating auditability as overhead especially risky in 2026?

Because automation is no longer evaluated privately. Regulatory changes taking effect through 2026 expose how automated systems behave at scale, particularly in prior authorization and claims workflows. Health plans are increasingly required to meet standardized decision timelines, provide clearer denial rationales, and report performance metrics that reflect how automation actually operates in production—a gap I routinely see when evaluating enterprise systems as a judge for the BIG – Excellence in Customer Service Awards

When auditability is treated as an afterthought, teams discover too late that they cannot invariably explain historical decisions. Retrofitting traceability into live systems is expensive and brittle, especially when policy logic, models, and data pipelines have already evolved. What looks like a compliance issue on paper becomes an operational one very quickly, as appeals slow down, manual review volumes increase, and confidence in automation erodes internally.

The risk in 2026 is not regulatory penalties alone. It is loss of control. Systems that cannot surface decision context on demand force organizations back into manual workflows at the worst possible moment—when scale, scrutiny, and reporting obligations are all increasing. Auditability is no longer overhead. It is the mechanism that allows automation to continue operating under pressure.

Looking forward, what will separate healthcare AI systems that scale sustainably from those that stall?

The dividing line will be architectural intent. Systems optimized solely for speed and accuracy will encounter friction as accountability demands increase. Systems built with evidence continuity at their core will scale precisely because they can survive challenge.

The future belongs to AI platforms that treat audit trails as infrastructure rather than overhead. These systems recognize that trust is not established through claims of intelligence, but through the ability to explain decisions clearly, consistently, and long after the fact. In healthcare, survivability under scrutiny is the true measure of automation maturity.